Palomino Laboratories (PALX) Total Current Liabilities (2022 - 2025)
Palomino Laboratories' (PALX) quarterly Total Current Liabilities came in at $336458.0 in Q4 2025, up 5131.81% year-on-year from $6431.0 in Q4 2024, and down 66.32% quarter-over-quarter from $999013.0 in Q3 2025.
Palomino Laboratories (PALX) Total Current Liabilities (2022 - 2025) Analysis & Trends
Palomino Laboratories has disclosed Total Current Liabilities across 4 years of filings, most recently posting $336458.0 for Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $336458.0, up 5131.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $336458.0 (up 5131.81% YoY), and the FY2025 annual result was $336458.0, up 5131.81% from the prior year.
- Total Current Liabilities came in at $336458.0 for Q4 2025 at Palomino Laboratories, down from $999013.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $999013.0 in Q3 2025 to a low of $6431.0 in Q4 2024.
- The 4-year median for Total Current Liabilities is $194658.0 (2024), against an average of $258284.6.
- Across the five-year window, Total Current Liabilities tumbled 94.24% in 2024 and soared 5131.81% in 2025, its largest moves.
- Palomino Laboratories' Total Current Liabilities stood at $27804.0 in 2022, then surged by 301.46% to $111621.0 in 2023, then sank by 94.24% to $6431.0 in 2024, then jumped by 5131.81% to $336458.0 in 2025.
- The last three Total Current Liabilities figures came in at $336458.0 (Q4 2025), $999013.0 (Q3 2025), and $364431.0 (Q2 2025), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336,458.00 |
| Sep 30, 2025 | 999,013.00 |
| Jun 30, 2025 | 364,431.00 |
| Mar 31, 2025 | 336,989.00 |
| Dec 31, 2024 | 6,431.00 |
| Sep 30, 2024 | 221,754.00 |
| Jun 30, 2024 | 194,658.00 |
| Mar 31, 2024 | 162,925.00 |
| Dec 31, 2023 | 111,621.00 |
| Sep 30, 2023 | 79,047.00 |
| Dec 31, 2022 | 27,804.00 |